Monovisc is a brand of hyaluronic acid (HA) injection used to treat knee pain due to osteoarthritis. The brand is produced by Anika Therapeutics, a global medical technology company.
Monovisc is a single injection treatment that delivers a high concentration of HA directly into the knee joint. HA is a naturally occurring substance found in the body’s synovial fluid, which helps to lubricate and cushion the joints. In people with osteoarthritis, the level of HA in the joint may be reduced, leading to joint pain and stiffness. By injecting additional HA into the joint, Monovisc can help to reduce pain and improve joint mobility.
Monovisc is designed to provide longer-lasting relief than traditional HA injections, with effects lasting for up to six months. It is administered by a healthcare professional such as an orthopedic surgeon, typically on an outpatient basis.